Owens & Minor, Inc.

Owens & Minor, Inc. Fundamental Analysis

OMINYSE
HealthcareMedical - Distribution
$2.68
$0.22(8.94%)
U.S. Market opens in 6h 7m

Owens & Minor, Inc. Fundamental Analysis

Owens & Minor, Inc. (OMI) shows weak financial fundamentals with a PE ratio of 14.39, profit margin of -2.69%, and ROE of 2.65%. The company generates $0.4B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position162.64%
PEG Ratio-0.01

Areas of Concern

ROE2.65%
Current Ratio0.49
We analyze OMI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -186.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-186.0/100

We analyze OMI's fundamental strength across five key dimensions:

Efficiency Score

Weak

OMI struggles to generate sufficient returns from assets.

ROA > 10%
-44.79%

Valuation Score

Excellent

OMI trades at attractive valuation levels.

PE < 25
14.39
PEG Ratio < 2
-0.01

Growth Score

Weak

OMI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

OMI shows balanced financial health with some risks.

Debt/Equity < 1
-1.40
Current Ratio > 1
0.49

Profitability Score

Weak

OMI struggles to sustain strong margins.

ROE > 15%
264.54%
Net Margin ≥ 15%
-2.69%
Positive Free Cash Flow
No

Key Financial Metrics

Is OMI Expensive or Cheap?

P/E Ratio

OMI trades at 14.39 times earnings. This suggests potential undervaluation.

14.39

PEG Ratio

When adjusting for growth, OMI's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Owens & Minor, Inc. at -0.45 times its book value. This may indicate undervaluation.

-0.45

EV/EBITDA

Enterprise value stands at -0.41 times EBITDA. This is generally considered low.

-0.41

How Well Does OMI Make Money?

Net Profit Margin

For every $100 in sales, Owens & Minor, Inc. keeps $-2.69 as profit after all expenses.

-2.69%

Operating Margin

Core operations generate 11.05 in profit for every $100 in revenue, before interest and taxes.

11.05%

ROE

Management delivers $2.65 in profit for every $100 of shareholder equity.

2.65%

ROA

Owens & Minor, Inc. generates $-44.79 in profit for every $100 in assets, demonstrating efficient asset deployment.

-44.79%

Following the Money - Real Cash Generation

Operating Cash Flow

Owens & Minor, Inc. generates limited operating cash flow of $-201.43M, signaling weaker underlying cash strength.

$-201.43M

Free Cash Flow

Owens & Minor, Inc. generates weak or negative free cash flow of $-181.03M, restricting financial flexibility.

$-181.03M

FCF Per Share

Each share generates $-2.34 in free cash annually.

$-2.34

FCF Yield

OMI converts -87.45% of its market value into free cash.

-87.45%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

14.39

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.45

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.51

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.40

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.49

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

2.65

vs 25 benchmark

ROA

Return on assets percentage

-0.45

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How OMI Stacks Against Its Sector Peers

MetricOMI ValueSector AveragePerformance
P/E Ratio14.3929.45 Better (Cheaper)
ROE264.54%417.00% Weak
Net Margin-268.96%-11442.00% (disorted) Weak
Debt/Equity-1.400.78 Strong (Low Leverage)
Current Ratio0.495.09 Weak Liquidity
ROA-44.79%-74.00% (disorted) Weak

OMI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Owens & Minor, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ